MANAGEMENT AND OUTCOME OF BASELINE GREYZONE ( GZ) PATIENTS AMONG THE FRENCH HEPATHER COHORT: IS IT DIFFERENT FROM HBEAG NEGATIVE CHRONIC HEPATITIS B INFECTION ( CHBVE-) OR HBEAG NEGATIVE CHRONIC HEPATITIS ( CHBVHE-)?

被引：0
|
作者：
Parlati, Lucia [1 ]
Lusivika, Clovis [2 ]
Nicol, Jerome [2 ]
Carrat, Fabrice [2 ]
Leroy, Vincent [3 ]
Bourliere, Marc [4 ]
机构：
[1] Cochin Hosp, Hepatol Dept, Kochi, Japan
[2] INSERM Paris, IPLESP, UMR S 1136, Paris, France
[3] Mondor Hosp, Hepatol Dept, Creteil, France
[4] Hop St Joseph, Paris, France
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
301
引用
收藏
页码：S215 / S216
页数：2
相关论文
共 50 条
  • [21] HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection
    Alexopoulou, Alexandra
    Karayiannis, Peter
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (24) : 7644 - 7652
  • [22] EFFICACY OF TELBIVUDINE IN THE TREATMENT OF HBeAg NEGATIVE CHRONIC HEPATITIS B WITH NORMAL BASELINE ALT LEVELS
    Mehr, Muhammad Tariq
    Khan, Humera
    Ul Iman, Noor
    Khan, Habibullah
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2012, 10 (01): : 104 - 106
  • [23] Correlation between baseline genotype and antiviral response to emtricitabine 200 mg QD among HBeAg negative patients with chronic hepatitis B infection
    Snow, A
    Guan, R
    Diamantis, I
    Sorbel, J
    Mondou, E
    Rousseau, F
    HEPATOLOGY, 2004, 40 (04) : 654A - 654A
  • [24] The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection
    Papatheodoridis, G. V.
    Manolakopoulos, S.
    Margariti, A.
    Papageorgiou, M. V.
    Kranidioti, H.
    Katoglou, A.
    Kontos, G.
    Adamidi, S.
    Kafiri, G.
    Deutsch, M.
    Pectasides, D.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (07) : 517 - 524
  • [25] Analysis of clinical and virologic features in Hepatitis B e Antigen (HbeAg)-negative and HbeAg-positive Egyptian chronic hepatitis B patients
    Fouad, Rabab
    Musa, Sherief
    Sabry, Dina
    Salama, Ahmad
    Alem, Shereen Abdel
    Atef, Mira
    Zayed, Naglaa
    AFRICAN HEALTH SCIENCES, 2020, 20 (02) : 649 - 655
  • [26] Reversion from HBeAg negative to HBeAg positive phenotype after interferon therapy for chronic hepatitis B.
    Kitis, G
    Ilias, A
    Kapetanos, D
    Kiriazis, G
    HEPATOLOGY, 1999, 30 (04) : 601A - 601A
  • [27] Genotypic and phenotypic resistance to lamivudine in patients with HBeAg negative chronic hepatitis B.
    Hussain, MT
    Carmela, C
    Gramenzi, A
    Fiorino, S
    Margotti, M
    Talarico, S
    Bernardi, M
    Andreone, P
    Lok, AS
    HEPATOLOGY, 2001, 34 (04) : 325A - 325A
  • [28] When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?
    Liaw Y.-F.
    Current Hepatology Reports, 2024, 23 (2) : 221 - 226
  • [29] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Amir Houshang Mohammad Alizadeh
    Mitra Ranjbar
    Babak Karimi
    Saeed Hatami
    World Journal of Gastroenterology, 2006, (26) : 4203 - 4205
  • [30] Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients
    Bacaksiz, Ferhat
    Gokcan, Hale
    Akdogan, Meral
    Gokce, Dilara Turan
    Ari, Derya
    Gokbulut, Volkan
    Ergun, Yakup
    Ozturk, Omer
    Kacar, Sabite
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
12345